Apollo Neuro sits in the consumer wellness segment as a vibrotactile wearable positioned around vagus nerve activation for stress, sleep, and focus, backed by an unusually extensive clinical evidence base for a non-medical device. Its direct-to-consumer distribution and Series A funding differentiate it from clinical neuromodulation companies, though the wellness-grade regulatory pathway limits its clinical credibility ceiling.